骨科药物治疗临床路径管理模式的建立与实践  

Establishment and Practice of the Refined Management Mode of Clinical Pathway for Medicine Treatment in Orthopaedic Department

作　　者：刘东华[1] 全香花[1] 邢晓敏[1] 韩冰[1] 周长凯[1] 曲海军[1] 刘月芬[1] 王龙源[1] 王堃[1] 荆凡波[1] LIU Donghua;QUAN Xianghua;XING Xiaomin;HAN Bing;ZHOU Changkai;QU Haijun;LIU Yuefen;WANG Longyuan;WANG Kun;JING Fanbo(Department of Pharmacy,the Affiliated Hospital of Qingdao University,Qingdao 266003,China)

机构地区：[1]青岛大学附属医院药学部,青岛266003

出　　处：《医药导报》2021年第1期139-143,共5页Herald of Medicine

基　　金：山东省自然科学基金资助项目(ZR2017MH045)。

摘　　要：目的促进骨科围手术期预防用抗菌药物和手术后镇痛药物的合理使用。方法建立基于药物治疗临床路径精细化管理模式,在骨科开展围手术期预防用抗菌药物和手术后镇痛药物的用药路径。结果药物治疗临床路径实施后,骨科抗菌药物使用强度、人均药费和每床日药费均显著降低,分别降低51.50%,23.86%和8.28%,在促进合理用药方面取得显著成效。结论建立药物治疗临床路径精细化管理模式,为促进合理用药管理提供了新思路。Objective To improve the rational use of antibiotic prophylaxis and postoperative analgesics in orthopaedics department.Methods Our hospital tried to establish a refined management model based on clinical pathway of medicine treatment,and carried out the drug route of perioperative prophylactic antibacterial drugs and analgesics in orthopedics departments.Results After the implementation of the clinical pathway of medicine treatment,the intensity of antimicrobial use,drug cost per capita,and daily drug cost per bed were significantly reduced by 51.50%,23.86%and 8.28%,respectively.Significant improvement have been achieved in promoting rational drug use.Conclusion The establishment of a refined management model of"Clinical Pathways for Medicine Treatment"provides a new idea to promote the rational drug administration.

关 键 词：药物治疗 临床路径 围手术期 抗菌药物 镇痛药物 骨科 

分 类 号：R978[医药卫生—药品] R971.2[医药卫生—药学]